Adjuvant Interferon Treatment of Condylomata Acuminata

  • K.-H. Tiedemann
Conference paper


Condylomata acuminata caused by human papillomavirus infection constitute one of the most common sexually transmitted diseases which is showing a worldwide increase of incidence [8, 10, 14]. Numerous therapeutic regimens are available such as conservative methods including application of podophyllin, fluorouracil, colchicine, or bleomycin solutions. The most widely employed surgical methods are electrocaustic resection of the warts, cryotherapy, and Neodym Yag or carbon dioxide laser therapy. Altogether these methods are not satisfying. The therapeutic procedures in most cases lead to a complete removal of the warts, but there is a high recurrence rate with all these methods. As Jensen [12] reported, the recurrence rate after 3 months is 43% after podophyllin application and 18% after electrocautery. Three months later more than 50% of the patients treated by electrocautery will again register the appearance of genital warts. Newer operative procedures such as laser resection may be easier to handle and lead to fewer side effects, but the rate of recurrence will be the same as after electrocaustic resection [15]. According to our observations in large (more than 7 mm diameter) and numerous (>20) warts and in warts which have been recalcitrant for more than 2 years the recurrence rate is higher still than mentioned in the study of Jensen [4, 15]. Thus, it is not uncommon for patients to consult their physician several times a year for more than 5 or even 10 years seeking relief for their recurring genital or perianal warts.


Genital Wart Interferon Therapy Condyloma Acuminata Adjuvant Interferon Interferon Injection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Creagan ET, Ahmann DL, Frytak S, Long HJ, Chang MN, Itri LM (1986) Phase II tials of recombinant leucocyte A interferon in disseminated malignant melanoma. Cancer Treat Rep 70: 619–626PubMedGoogle Scholar
  2. 2.
    De Villiers E-M, Wagner D, Schneider A, Wesch H, Miklaw H, Wahrendorf J, Papendick U, zur Hausen H (1987) Human papillomaviruses in women with and without abnormal cervical cytology. Lancet 11 (8561): 703–705CrossRefGoogle Scholar
  3. 3.
    Douglas JM, Royers M, Judson FN (1986) The effect of asymptomatic infection with HTLV III on the response of anogenital warts to intralesional treatment with recombinant alpha-2 interferon. J Infect Dis 154 (2): 331–334PubMedCrossRefGoogle Scholar
  4. 4.
    Eron LJ, Judson F, Tucker S, Prawer S, Mills J, Murphy K, Hickey M, Rogers M, Flanningan S, Hien N, Katz HI, Gottlieb A, Adams K, Burton P, Tanner D, Taylor E, Peets E (1986) Interferon therapy for condylomata acuminata. N Engl J Med 315 (17): 1059–1064PubMedCrossRefGoogle Scholar
  5. 5.
    Erpenbach K, Derschum W, Wiese H, v. Vietsch H (1989) Results of the combined laser and adjuvant interferon alpha 2B therapy for patients with therapy resistant anogenital condylomata acuminata. International symposium of advances in diagnosis and therapy of genital papillomavirus infections, Hamburg, Feb 3–5, 1989 (abstracted)Google Scholar
  6. 6.
    Esposito R, Orlando G,Lazzarin A, Chianura Castagna A, Verani P, Noroni M (1986) Recombinant alpha interferon treatment of AIDS-related Kaposi sarcoma. J Interferon Res 6: 46Google Scholar
  7. 7.
    Gall SA, Hughes CE, Trofatter K (1985) Interferon for the therapy of condylomata acuminata. Am J Obstet Gynecol 153 (2): 157–163PubMedGoogle Scholar
  8. 8.
    Gissmann L, Gross G (1985) Association of human papilloma viruses with human genital tumors. Clin Invest Dermatol 3: 124–126Google Scholar
  9. 9.
    Gross G, de Villiers EM, Roussaki A, Papendick U, Schöpf E (1986) Successful treatment of condylomata acuminata and bowenoid papulosis with subcutaneous injections of low dose recombinant interferon-alpha. Arch Dermatol 122: 749–750PubMedCrossRefGoogle Scholar
  10. 10.
    Gross G, Pfister H, Gissmann L, Hagedorn M (1982) Correlation between human papillomavirus ( HPV) type and histology of warts. J Invest Dermatol 78: 160–164PubMedCrossRefGoogle Scholar
  11. 11.
    Hohenleutner U, Landthaler M, Braun-Falco O, Schmoeckel C, Hans D (1988) Condylomata acuminata gigantea; Behandlung mit dem CO2-Laser und Interferon. Dtsch Med Wochenschr 113: 985–987PubMedCrossRefGoogle Scholar
  12. 12.
    Jensen SL (1985) Comparison of podophyllin application with simple surgical excision in clearance of perianal condylomata acuminate. Lancet 11: 1146–1148CrossRefGoogle Scholar
  13. 13.
    Kirchner H (1984) Interferons. A group of multiple lymphokines Immunopathology 2: 347–374Google Scholar
  14. 14.
    Lowy DR, Androphy EJ (1987) Warts. In: Fitzpatric TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds) Dermatology in general Medicine, 3rd edn. McGraw-Hill, New York, pp 2355–2372Google Scholar
  15. 15.
    Duus BR, Philipsen T, Christensen JD, Lundvall F, Sondergaard J (1985) Refractory condylomata acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treatment. Genitourin Med 61: 59–61PubMedGoogle Scholar
  16. 16.
    Tiedemann KH, Ernst ThM (1988) Kombinationstherapie von rezidivierenden Condylomata acuminata mit Elektrokaustik und Alpha-2-Interferon. Aktuel Dermatol 14: 200–204Google Scholar
  17. 17.
    Trofatter KFJ, English PC, Hughes CE, Gall SA (1986) Human lymphoblastoid interferon in primary therapy of two children with condylomata acuminata. Obstet Gyneco167(1): 137–140Google Scholar
  18. 18.
    Vance JB, Bart BJ, Hansen RC, Reichman RC, Mcewen C, Hatch KD, Berman B, Tanner DJ (1986) Intralesional recombinant alpha-2 interferon for the treatment of patients with condylomata acuminata or verruca plantaris. Arch Dermatol 122: 272–277PubMedCrossRefGoogle Scholar
  19. 19.
    Weck PhD, Debra A, Buddin MSN, Wisnant JK (1988) Interferons in the treatment of genital human papillomavirus infections. Am J Med 85 [Suppl 2a]: 159–164PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • K.-H. Tiedemann

There are no affiliations available

Personalised recommendations